|
NCRNA00171 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.663600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.438200E-01 |
| Normal-vs-Stage2 |
8.156600E-01 |
| Normal-vs-Stage3 |
1.609630E-02 |
| Normal-vs-Stage4 |
1.165080E-04 |
| Stage1-vs-Stage2 |
8.440600E-01 |
| Stage1-vs-Stage3 |
1.796360E-02 |
| Stage1-vs-Stage4 |
1.75479999999784E-05 |
| Stage2-vs-Stage3 |
8.899800E-02 |
| Stage2-vs-Stage4 |
7.458400E-03 |
| Stage3-vs-Stage4 |
2.296600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.072400E-02 |
| Normal-vs-AfricanAmerican |
6.757800E-01 |
| Normal-vs-Asian |
4.132600E-01 |
| Caucasian-vs-AfricanAmerican |
2.780200E-01 |
| Caucasian-vs-Asian |
1.503030E-01 |
| AfricanAmerican-vs-Asian |
4.167200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.569800E-02 |
| Normal-vs-Female |
1.751770E-01 |
| Male-vs-Female |
6.802600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.615360E-01 |
| Normal-vs-Age(41-60Yrs) |
2.943800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.667900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.618000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.534000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.544200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.082400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.025200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.888200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.501800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.641700E-02 |
| Normal-vs-Grade 2 |
4.715400E-01 |
| Normal-vs-Grade 3 |
2.457700E-02 |
| Normal-vs-Grade 4 |
4.199000E-03 |
| Grade 1-vs-Grade 2 |
1.720050E-02 |
| Grade 1-vs-Grade 3 |
8.371600E-04 |
| Grade 1-vs-Grade 4 |
1.678250E-03 |
| Grade 2-vs-Grade 3 |
4.911800E-02 |
| Grade 2-vs-Grade 4 |
5.299400E-03 |
| Grade 3-vs-Grade 4 |
1.547410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.640400E-01 |
| Normal-vs-ccB subtype |
5.857600E-03 |
| ccA subtype-vs-ccB subtype |
4.566300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.512220E-01 |
| Normal-vs-N1 |
1.401100E-03 |
| N0-vs-N1 |
1.328010E-02 |
|
|
